← Leaderboards
Alpaslan Dedeoglu
Boston University Medical Campus
$7,018,151
Attributed
$11,796,924
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,796,924 · 6
VA$0 · 5
By mechanism
RF1$8,900,278 · 3
R01$2,605,267 · 2
R21$291,379 · 1
I01$0 · 3
I21$0 · 2
Top collaborators
- Bruce Jenkins3 shared
- Ibrahim Alpdogan Kantarci1 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Lawreen H. Connors$2,106,272
- Benjamin L Wolozin$31,159,035
- Robert C. Green$38,307,859
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainMouse ModelNeurochemistryPreventMagnetic Resonance SpectroscopyPharmacologyMemoryDoseAffectS DiseaseFunctional DisorderSignal TransductionReportingGenesCognitiveS Disease ModelIn VivoAnimal ModelPathologyNeuronsEtiologyImaging TechniquesReceptor
Grant awards (27)
Protective roles of taurine in Alzheimer's disease brain$657,269
R01 · FY2024 · AG
Sphingosine-1-phosphate system as a therapeutic target for amyotrophic lateral sclerosis$0
I01 · FY2024 · VA · contact PI
Sphingosine-1-phosphate system as a therapeutic target for amyotrophic lateral sclerosis$0
I01 · FY2023 · VA · contact PI
Sphingosine-1-phosphate system as a therapeutic target for amyotrophic lateral sclerosis$0
I01 · FY2022 · VA · contact PI
Targeting the sphingosine-1-phosphate system in a mouse model of Gulf War Veterans' Illness$0
I21 · FY2021 · VA · contact PI
Targeting the sphingosine-1-phosphate system in a mouse model of Gulf War Veterans' Illness$0
I21 · FY2021 · VA · contact PI
Sphingosine-1-phosphate system as a therapeutic target for amyotrophic lateral sclerosis$0
I01 · FY2021 · VA · contact PI
Protective roles of taurine in Alzheimer's disease brain$2,337,294
RF1 · FY2020 · AG
Mechanistic link between Alzheimer's disease and periodontitis$3,732,218
RF1 · FY2019 · AG · contact PI
Sphingosine-1-phosphate induced modulation of inflammation in aging and Alzheimer's disease$2,830,766
RF1 · FY2017 · AG · contact PI
Novel neurotrophic therapies in an optimized mouse model of GWVI$0
I01 · FY2017 · VA · contact PI
Cholinergic neurons and memory in GFP-AD mouse: a novel neurotrophic therapy$0
I01 · FY2017 · VA · contact PI
Cholinergic neurons and memory in GFP-AD mouse: a novel neurotrophic therapy$0
I01 · FY2016 · VA · contact PI
Novel neurotrophic therapies in an optimized mouse model of GWVI$0
I01 · FY2016 · VA · contact PI
Cholinergic neurons and memory in GFP-AD mouse: a novel neurotrophic therapy$0
I01 · FY2015 · VA · contact PI
Novel neurotrophic therapies in an optimized mouse model of GWVI$0
I01 · FY2015 · VA · contact PI
Novel neurotrophic therapies in an optimized mouse model of GWVI$0
I01 · FY2014 · VA · contact PI
Cholinergic neurons and memory in GFP-AD mouse: a novel neurotrophic therapy$0
I01 · FY2014 · VA · contact PI
Novel neurotrophic therapy in a mouse model of ALS$0
I21 · FY2014 · VA · contact PI
Cyclohexanehexol Therapy in Transgenic Models of Alzheimer's Disease$360,859
R01 · FY2013 · AG · contact PI
Novel neurotrophic therapy in a mouse model of ALS$0
I21 · FY2013 · VA · contact PI
Cyclohexanehexol Therapy in Transgenic Models of Alzheimer's Disease$381,861
R01 · FY2012 · AG · contact PI
Cyclohexanehexol Therapy in Transgenic Models of Alzheimer's Disease$381,863
R01 · FY2011 · AG · contact PI
Cyclohexanehexol Therapy in Transgenic Models of Alzheimer's Disease$389,776
R01 · FY2010 · AG · contact PI
Cyclohexanehexol Therapy in Transgenic Models of Alzheimer's Disease$433,639
R01 · FY2009 · AG · contact PI
Integrated Neuroimaging and Pathology of Alzheimer Mice$130,729
R21 · FY2006 · AG · contact PI
Integrated Neuroimaging and Pathology of Alzheimer Mice$160,650
R21 · FY2005 · AG